# IXI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ixi-2

- Industry: Healthcare Specialists
- Headquarters: Espoo, Finland
- Website: www.ixieyewear.com
- Total disclosed funding: $41M
- Latest round: Series A (Apr 28, 2025)
- Investors on record: 13

## About

Based in Finland, IXI specializes in adaptive eyewear technology that automatically adjusts focus based on user eye movements, providing a tailored vision correction experience for diverse visual tasks.Founded in 2021 in Espoo, Finland, IXI develops innovative eyewear solutions. The founders Klaus Melakari, Rebecca Melakari, and Ville Miettinen, have positioned the company to revolutionize the optical industry. IXI has successfully conducted three funding rounds, with the most recent being a SERIES A round on April 28, 2025, where it raised EUR 32.2 mn led by Plural UK Management and supported by notable investors including Amazon and Eurazeo. The total amount raised by the company is EUR 32.2 mn.IXI is pioneering the eyewear industry with its innovative core product, the IXI Adaptive Eyewear, which features lenses that automatically adjust focus based on the user's eye movements. This technology allows seamless transitions between near and far viewing, catering to individuals requiring dynamic vision correction. The product aims to enhance user experiences by providing an adaptive solution that accommodates various visual tasks, significantly improving daily activities such as reading, driving, or using electronic devices. Currently, IXI Adaptive Eyewear is in development and has not yet been released to the market, with potential reach in developed regions with strong demand for optical solutions, such as North America and Europe.IXI's revenue details for the most recent year, 2022, indicate an amount of EUR 0. The EBITDA for 2023 is reported as EUR -4,874,155.40. The company anticipates a direct-to-consumer sales model, likely using online platforms and partnerships with retail eyewear outlets. Revenue generation will likely involve one-time purchases or subscription-based models for lens updates and maintenance, positioning the IXI Adaptive Eyewear at a premium price point due to its advanced technology and design.In April 2025, IXI raised EUR 32.2 mn in SERIES A funding, led by Plural UK Management, to complete the development of its autofocus glasses and launch commercial operations. This funding will support the introduction of real-time adaptive eyewear to the market. The company aims for a release of its innovative product in the near future, with plans to expand into markets in North America and Europe, targeting consumers who require advanced optical solutions.

## Funding rounds

- Series A, Apr 28, 2025, $37M — Eurazeo, Tesi, Heartcore Capital, Bragiel Brothers, Tiny Super Computer Investment Company, byFounders, Maki.vc, Illusian Group, First Fellow Partners, Amazon, FOV Ventures, Plural
- Seed, Jun 9, 2021, $4.4M — Bragiel Brothers, Firstminute Capital, Maki.vc, Amazon, First Fellow Partners

## Investors

- Bragiel Brothers (https://capitalatlas.ai/funds/bragiel-brothers) — Seed, Series A
- Firstminute Capital (https://capitalatlas.ai/funds/firstminute-capital) — Seed
- Maki.vc (https://capitalatlas.ai/funds/maki-vc) — Seed, Series A
- Amazon (https://capitalatlas.ai/funds/amazon) — Seed, Series A
- First Fellow Partners (https://capitalatlas.ai/funds/first-fellow-partners) — Seed, Series A
- Eurazeo (https://capitalatlas.ai/funds/eurazeo) — Series A
- Tesi (https://capitalatlas.ai/funds/tesi) — Series A
- Heartcore Capital (https://capitalatlas.ai/funds/heartcore-capital) — Series A
- Tiny Super Computer Investment Company (https://capitalatlas.ai/funds/tiny-super-computer-investment-company) — Series A
- byFounders (https://capitalatlas.ai/funds/byfounders) — Series A
- Illusian Group — Series A
- FOV Ventures (https://capitalatlas.ai/funds/fov-ventures) — Series A
- Plural (https://capitalatlas.ai/funds/plural) — Series A